Renal recovery after injury: The role of Pax-2

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2628-2633

  Lindoso, Rafael S ^a   Verdoorn, Karine S ^a   Einicker Lamas, Marcelo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Kidney disease; Pax 2; Renal regeneration; Signalling

Indexed keywords

ACTIVIN A; TRANSCRIPTION FACTOR PAX2;

DOWN REGULATION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; UPREGULATION;

ACTIVINS; ANIMALS; HUMANS; KIDNEY; MODELS, BIOLOGICAL; PAX2 TRANSCRIPTION FACTOR; REGENERATION; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 69249109548     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp307     Document Type: Review

References (70)

1. Saikumar P, Venkatachalam MA. Role of apoptosis in hypoxic/ ischemic damage in the kidney. Semin Nephrol 2003; 23: 511-521
2. van de Water B, de Graauw M, Le Dévédec S et al. Cellular stress responses and molecular mechanisms of nephrotoxicity. Toxicol Lett 2006; 162: 83-93
3. Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med 2008; 36: S187-S192
4. Cybulsky AV. Growth factor pathways in proliferative glomerulonephritis. Curr Opin Nephrol Hypertens 2000; 9: 217-223
5. Hallman MA, Zhuang S, Schnellmann RG. Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. J Pharmacol Exp Ther 2008; 325: 520-528
6. Imgrund M, Gr̈one E, Gr̈one HJ et al. Re-expression of the development gene Pax-2 during experimental acute tubular necrosis in mice. Kidney Int 1999; 56: 1423-1431
7. Witzgall R, Brown D, Schwarz C et al. Localization of proliferating cell nuclear antigen, vimentin, c-fos and cluterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93: 2175-2188
8. Abbate M, Brown D, Bonventre JV. Expression of NCAM recapitulates tubulogenic development in kidneys recovering from acute ischemia. Am J Physiol 1999; 277: F454-F463
9. Safirstein R. Gene Expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 1994; 56: 1299-1304
10. Nadasdy T, Laszik Z, Blick KE et al. Proliferative activity of intrinsic cell populations in the normal human Kidney. J AmSoc Nephrol 1994; l4: 2032-2039
11. Davies JA, Bard JBL. The development of the kidney. Curr Top Dev Biol Med 1997; 215: 209-222
12. Nigam SK, Liberthal W. Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol 2000; 279: F3-F11
13. Rothenpieler UW, Dressler GR. Pax-2 is required for mesenchymeto- epithelium conversion during kidney development. Development 1993; 119: 711-720
14. Dziarmaga A, Hueber PA, Iglesias D et al. Neuronal apoptosis inhibitory protein (NAIP) is expressed in development kidney and is regulated by PAX2. Am J Physiol Renal Physiol 2006; 291: F913-F920
15. Goulding MD, Chalepakis G, Deutsch U et al. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 1991; 10: 1135-1147
16. Torban E, Dziarmaga A, Iglesias D et al. PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem 2006; 281: 12705-12712
17. Buckingham M. Skeletal muscle progenitor cells and the role of Pax genes. C R Biol 2007; 330: 530-533
18. Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays 1997; 19: 755-765
19. Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet 2002; 18: 41-47
20. Ward TA, Nebel A, Reeve AE et al. Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. Cell Growth Differ 1994; 5: 1015-1021
21. Eccles MR, He S, Legge M et al. PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol 2002; 46: 535-544
22. Eccles MR, Wallis LJ, Fidler AE et al. Expression of the Pax2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 1992; 3: 279-289
23. Torres M, Gomez-Pardo E, Dressler G et al. Pax-2 controls multiples steps of urogenital development. Development 1995; 121: 4057-4065
24. Dressler GR, Wilkinson JE, Rothenpieler UW et al. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993; 362: 65-67
25. Winyard PJ, Risdon RA, Sams VR et al. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clinical Invest 1996; 98: 451-459
26. Fickenscher HR, Chalepakis G, Gruss P. Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system. DNA Cell Biol 1993; 12: 381-391
27. Epstein J, Cai J, Glaser T et al. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Chem 1994; 269: 8355-8361
28. Dehbi M, Ghahremani M, LecherMet al. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 1996; 13: 447-453
29. Stark K, Vainio S, Vassileva G et al. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 1994; 372: 679-683
30. Zhang SL, Chen YW, Tran S et al. Pax-2 andN-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol 2007; 22: 813-824
31. Grote D, Souabni A, Busslinger M et al. Pax2/8-regulated Gata3 expression is necessary formarphogenesis and guidance of the nephric duct in the developing kidney. Development 2006; 133: 53-61
32. Sariola H, Saarma M. Novel functions and signaling pathways for GDNF. J Cell Sci 2003; 116: 3855-3862
33. Brophy PD, Lang KM, Dressler GR. The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax2 transcriptional factor. J Biol Chem 2003; 278: 52401-52405
34. Self M, Lagutin OV, Bowling B et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J 2006; 25: 5214-5228
35. Stuart ET, Haffner R, Oren M et al. Loss of p53 function through PAX-mediated transcriptional repression. EMBO J 1995; 14: 5638-5645
36. Torban E, Eccles MR, Favor J et al. Pax2 suppresses apoptosis in renal collecting duct cells. Am J Pathol 2000; 157: 833-842
37. Maeshima A, Maeshima K, Nojima Y et al. Involvement of Pax-2 in the action of activin A on tubular cell regeneration. J Am Soc Nephrol 2002; 13: 2850-2859
38. Zhang SL, Guo J,Moini B et al. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int 2004; 66: 2181-2192
39. Maeshima A, Yamashita S, Maeshima K et al. Activin A produced by ureteric bud is a differentiation factor for metanephric mesenchyme. J Am Soc Nephrol 2003; 14: 1523-1534
40. Shimonaka M, Inouye S, Shimasaki S et al. Follistatin binds to both activin an inhibin through the common subunit. Endocrinology 1991; 128: 3313-3315
41. Liu S, CieslinskiDA, FunkeAJ et al. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Exp Nephrol 1997; 5: 295-300
42. Shen W, Brown NS, Finn PF et al. Akt and Mammalian target of rapamycin regulate separate systems of proteolysis in renal tubular cells. J Am Soc Nephrol 2006; 17: 2414-2423
43. Berry C, Touyz R, Dominiczak AF et al. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001; 281: 2337-2365
44. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003; 144: 2179-2183
45. Sanyanusin P, Schimmenti LA, McNoe LA et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9: 358-364
46. Matsusaka T, Miyazaki Y, Ichikawa I. The rennin-angiotensin system and kidney development. Annu Rev Physiol 2002; 64: 551-561
47. Kontogiannis J and Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998; 274: F79-F90
48. Zhang SL, Moini B, Ingelfinger JR. Angiotensin II increases Pax-2 expression in fetal kidney cells via theAT2 receptor. J AmSoc Nephrol 2004; 15: 1452-1465
49. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996; 93: 156-160
50. Zimpelmann J, Burns KD. Angiotensin II AT2 receptors inhibit growth responses in proximal tubule cells. Am J Physiol Renal Physiol 2001; 281: F300-F308
51. Cao Z, Kelly DJ, Cox A et al. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int 2000; 58: 2437-2451
52. Windt WA, Eijkelkamp WB, Henning RH et al. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. J Am Soc Nephrol 2006; 17:3059-3066
53. Hashimoto N, Maeshima Y, Satoh M et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 2004; 286: F516-F525
54. Shankland SJ,Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000; 278: F515-F529
55. Maeshima A, Nojima Y, Kojima I. Activin A: An autocrine regulator of cell growth and differentiation in renal proximal tubular cells. Kidney Int 2002; 62: 446-454
56. Meunier H, Rivier C, Evans RM et al. Gonadal and extragonadal expression of inhibin α, βA and βB subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 1988; 85: 247-251
57. Tuuri T, Er̈amaa M, Hildén K et al. The tissue distribution of activin βA and βB subunits and follistatin mRNA suggests multiple sites of action of the activin-follistatin system during human development. J Clin Endocrinol Metab 1994; 78: 1521-1524
58. Maeshima A, Zhang YQ, Nojima Y et al. Involvement of activinfollistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol 2001; 12: 1685-1695
59. Yamashita S, Maeshima A, Kojima I et al. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004; 15: 91-101
60. Mather JP,MooreA, LiRH. Activins, inhibins and follistatins: Further thoughts on a growing family of regulators. Proc Soc Exp Biol Med 1997; 215: 209-222
61. Nakamura T, Takio K, Eto Y et al. Activin-binding protein from rat ovary is follistatin. Science 1990; 247: 836-838
62. Maeshima A, Vaughn DA, Choi Y et al. Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct. Dev Biol 2006; 295: 473-485
63. Dijke P, Hill CS. New insights into TGF-beta-Smad signaling. Trends Biochem Sci 2004; 29: 265-273
64. Yamaguchi K, Shirakabe K, Shibuya H et al. Identification of a member of theMAPKKKfamily as a potential mediator of TGF-beta signal transduction. Science 1995; 270: 2008-2011
65. Shi Y,Massague J. Mechanism of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700
66. Cocolakis E, Lemay S,Ali S et al. The p38MAPKpathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 2001; 276: 18430-18436
67. Ogihara T, Watada H, Kanno R et al. p38 MAPK is involved in activin A-and hepatocyte growth factor-mediated expression of proendocrine gene neurogenin 3 in AR42J-B13 cells. J Biol Chem2003; 278: 21693-21700
68. Zhang L, Deng M, Parthasarathy R et al. MEKK1 transduces activins signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 2005; 25: 60-65
69. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997; 214: 27-40
70. Basile DP, Rovak JM, Martin DR et al. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 1996; 270: F500-F509